Herbs (Global Traditional) · Southeast Asian
Temulawak (Curcuma xanthorrhiza) (Curcuma xanthorrhiza)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Temulawak (Curcuma xanthorrhiza) is a medicinal ginger family plant containing germacrone as its primary bioactive compound. It demonstrates hepatoprotective and anti-inflammatory effects through modulation of liver enzyme activity and inflammatory pathways.
Temulawak (Curcuma xanthorrhiza Roxb.) is a perennial herbaceous plant in the Zingiberaceae family native to Indonesia and Malaysia, primarily sourced from its rhizomes. The rhizomes are typically extracted using solvents like methanol, ethyl acetate, or water to isolate bioactive compounds including xanthorrhizol, germacrone, and curcumin.
Current research on temulawak is limited to preclinical studies with no human clinical trials, RCTs, or meta-analyses available. Animal studies demonstrate hepatoprotective effects against chemical-induced liver damage, while in vitro research shows promising anti-inflammatory and cytotoxic activities, though human efficacy remains unestablished.
No clinically studied human dosage ranges are available as all current research is preclinical. Animal hepatoprotective studies used intraperitoneal extracts without quantified human-equivalent doses. Consult a healthcare provider before starting any new supplement.
Temulawak (Curcuma xanthorrhiza) rhizome is primarily valued for its bioactive compounds rather than macronutrient content. **Bioactive compounds:** The rhizome contains 1.6–2.2% curcuminoids (primarily xanthorrhizol, curcumin, demethoxycurcumin, and bisdemethoxycurcumin), with xanthorrhizol being the signature compound at approximately 32–64 mg/100g dry weight, distinguishing it from common turmeric. Essential oil content ranges from 3–12% of dry weight, composed largely of ar-turmerone (~25–30% of oil), β-curcumene, xanthorrhizol (~15–30% of oil), and germacrone (~5–15% of oil). **Starch and fiber:** The rhizome is notably starch-rich (40–50% dry weight), making it a traditional source of digestible carbohydrate in Indonesian cuisine. Crude fiber content is approximately 4–8% dry weight. **Protein and fat:** Crude protein is low at approximately 4–7% dry weight; crude fat ranges from 4–11% dry weight, largely comprising the volatile and fixed oil fractions. **Minerals:** Potassium (~1,200–1,800 mg/100g dry weight), calcium (~80–200 mg/100g dry weight), magnesium (~100–200 mg/100g dry weight), iron (~15–40 mg/100g dry weight), phosphorus (~150–300 mg/100g dry weight), and zinc (~2–5 mg/100g dry weight). **Vitamins:** Small amounts of vitamin C (~5–10 mg/100g fresh weight) and traces of B-vitamins; not a significant vitamin source. **Other bioactives:** Contains phenolic acids, flavonoids, and sesquiterpenoids contributing to antioxidant capacity (ORAC values comparable to other Curcuma species). **Bioavailability notes:** Curcuminoids from temulawak share the poor oral bioavailability characteristic of curcumin (<5% without enhancement), due to rapid hepatic metabolism and poor aqueous solubility. However, xanthorrhizol demonstrates relatively higher bioavailability compared to curcumin due to its lipophilic sesquiterpenoid structure. Traditional preparation as 'jamu' (boiled with coconut milk or oils) may enhance absorption of lipophilic compounds. Co-consumption with piperine or lipid-rich foods can increase curcuminoid bioavailability 5–20-fold. The high starch content means the rhizome also provides caloric energy (~150–170 kcal/100g fresh weight).
Temulawak's germacrone-rich fractions modulate hepatic enzyme systems, reducing serum transaminase levels and protecting against oxidative liver damage. The compound appears to inhibit inflammatory mediator production through suppression of pro-inflammatory cytokine pathways. Hepatoprotective effects involve enhancement of antioxidant enzyme activity and reduction of lipid peroxidation in liver tissue.
Current evidence for temulawak comes primarily from animal studies demonstrating liver protection against acetaminophen and carbon tetrachloride-induced damage. Mouse studies showed significant reductions in serum transaminase levels, indicating preserved liver function. Anti-inflammatory activity has been demonstrated in animal models using germacrone-rich extracts. Human clinical trials are limited, making the translation of these animal findings to human applications uncertain.
Safety data for temulawak in humans is limited due to lack of comprehensive clinical trials. As a member of the ginger family, it may share similar interaction profiles with anticoagulant medications and could potentially enhance bleeding risk. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with liver conditions should consult healthcare providers before use, despite its traditional hepatoprotective reputation.
